Clinical Trial

Tdose Binding and Tocilizumab

Name: Tdose Binding and Tocilizumab — clinical trial record (NCT07582185)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TCZ

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The investigators aim to evaluate the non-inferiority of administering tocilizumab at a fixed dose versus a weight-based dose in patients with rheumatoid arthritis in remission or with low clinical activity, after 3 months of treatment, as part of a two-center randomized trial.

Trial Details

NCT Number	NCT07582185
Lead Sponsor	Centre Hospitalier Universitaire de Nice
Conditions	Rheumatoid Arthritis
Enrollment	122 participants
Start Date	2026-06-01
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-12